Celltrion will be attending the Morgan Stanley 22nd Annual Global Healthcare Conference in Marriott Marquis New York. #Savethedate as our Chairman and CEO will be presenting at a fireside chat on Friday, September 6. Learn more at: https://shorturl.at/X9KcB
소개
Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9
- 웹사이트
-
https://www.celltrion.com/en-us
Celltrion Inc 외부 링크
- 업계
- 제약
- 회사 규모
- 직원 1,001 - 5,000명
- 본사
- Incheon
- 유형
- 상장기업
- 전문 분야
- To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics.
위치
-
기본
길 보기
4F, 19, Academy-ro 51, Yeonsu-gu, Incheon, Korea 22014
KR Incheon 406-081
Celltrion Inc 직원
업데이트
-
BREAKING NEWS: We are pleased to announce the EC approval of an #ustekinumab #biosimilar. This approval represents a significant milestone for Celltrion in Europe, as we aim to lead the way in providing patient-centric care for autoimmune diseases in this market. View press release here: https://shorturl.at/Y3mTF
-
-
August is National Eye Exam Month, a timely reminder to care for your vision by booking an eye appointment. Regular eye exams are crucial for detecting any ophthalmic conditions. Book an eye exam this month and stay on top of your eye health! 👁 ❤️ #NationalEyeExamMonth #HealthyVision #Ophthalmology
-
-
Join us at Celltrion and dare to go beyond. 셀트리온 해외영업 주재원 분야 수시채용에 많은 지원 바랍니다. 👉 https://lnkd.in/evPCaZvN
-
-
Shared decision-making between healthcare providers and patients can have huge benefits. Listen to Prof. Nicolas Mathieu, gastroenterologist at MICI Institut Privé Clinique des Cèdres Echirolles, as he discusses some of the key elements of this shared decision-making. #IBD
-
We announced our Q2 2024 earning release on 7 August. Read full report at: https://bit.ly/4dBPTLc
-
While considering patients’ unmet needs when choosing their care options, healthcare professionals also have unmet needs in treatment. Prof. Alessandro Armuzzi, full Professor and Director of the Residency Program in Gastroenterology at Humanitas University shares his thoughts on the unmet need physicians face when treating #IBD patients.
-
This #WorldLungCancerDay, we want to shine a light on the importance of accessibility of medicines in treating lung cancer. We are dedicated to supporting people with lung cancer and reaffirm our commitment to oncology by working to ensure that quality healthcare is accessible for all. #WLCD2024
-
-
At Celltrion, we believe it is our responsibility to nurture the next generation of talent. In recognition of our commitment towards young talent, we would like to share the inspiring journey of our intern, highlighting how she brought passion, creativity, and value during her time with us. 😊 #NationalInternDay #LifeAtCelltrion #Internship
-
-
People living with #IBD must overcome many obstacles in their day-to-day lives, from managing symptoms to keeping on top of appointments. Hear from Prof. Dominik Bettenworth, Professor of Gastroenterology at Westfälische Wilhelms-Universität Münster sharing his thoughts on considerations in deciding the optimal treatment.